Literature DB >> 2157065

Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice.

D M Bass1, D Bodkin, R Dambrauskas, J S Trier, B N Fields, J L Wolf.   

Abstract

Oral inoculation of suckling mice with reovirus serotype 1 (strain Lang) results in the conversion of intact virions to intermediate subviral particles (ISVPs) in the intestinal lumen. Digestion of virus in vitro with chymotrypsin or trypsin reveals two distinct forms of ISVPs, while the predominant species of ISVPs found in the small intestinal lumen appears to be identical to the chymotrypsin product. The in vivo conversion of virions to ISVPs was blocked by pretreatment of mice with protease inhibitors, resulting in inefficient replication of reovirus in intestinal tissue. The early inhibition of viral replication in suckling mice pretreated with protease inhibitors was not observed when suckling mice were inoculated with ISVPs generated by in vitro digestion with either chymotrypsin or trypsin. However, replication was decreased during secondary rounds of replication in mice receiving repeated doses of protease inhibitors, suggesting that luminal proteolytic digestion is important in rendering progeny virions infectious in the gut.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157065      PMCID: PMC249324          DOI: 10.1128/JVI.64.4.1830-1833.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Reovirus serotype 1 intestinal infection: a novel replicative cycle with ileal disease.

Authors:  D H Rubin; M J Kornstein; A O Anderson
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

2.  Inhibitory effect of a protease inhibitor, leupeptin, on the development of influenza pneumonia, mediated by concomitant bacteria.

Authors:  M Tashiro; H D Klenk; R Rott
Journal:  J Gen Virol       Date:  1987-07       Impact factor: 3.891

3.  Serial propagation of astrovirus in tissue culture with the aid of trypsin.

Authors:  T W Lee; J B Kurtz
Journal:  J Gen Virol       Date:  1981-12       Impact factor: 3.891

4.  The sigma 1 protein determines the extent of spread of reovirus from the gastrointestinal tract of mice.

Authors:  R S Kauffman; J L Wolf; R Finberg; J S Trier; B N Fields
Journal:  Virology       Date:  1983-01-30       Impact factor: 3.616

5.  Activation and characterization of the reovirus transcriptase: genetic analysis.

Authors:  D Drayna; B N Fields
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

6.  Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity.

Authors:  M Tashiro; P Ciborowski; M Reinacher; G Pulverer; H D Klenk; R Rott
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

7.  Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.

Authors:  M Tashiro; M Homma
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Role of respiratory tract proteases in infectivity of influenza A virus.

Authors:  C L Barbey-Morel; T N Oeltmann; K M Edwards; P F Wright
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

9.  Suppression of influenza virus replication in infected mice by protease inhibitors.

Authors:  O P Zhirnov; A V Ovcharenko; A G Bukrinskaya
Journal:  J Gen Virol       Date:  1984-01       Impact factor: 3.891

10.  Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine.

Authors:  J L Wolf; R S Kauffman; R Finberg; R Dambrauskas; B N Fields; J S Trier
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

View more
  56 in total

1.  Proteolytic processing of the astrovirus capsid.

Authors:  D M Bass; S Qiu
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Structure of the reovirus outer capsid and dsRNA-binding protein sigma3 at 1.8 A resolution.

Authors:  A M Olland; J Jané-Valbuena; L A Schiff; M L Nibert; S C Harrison
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

3.  Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3.

Authors:  Judit Jané-Valbuena; Laura A Breun; Leslie A Schiff; Max L Nibert
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  The delta region of outer-capsid protein micro 1 undergoes conformational change and release from reovirus particles during cell entry.

Authors:  Kartik Chandran; John S L Parker; Marcelo Ehrlich; Tomas Kirchhausen; Max L Nibert
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  Impact of host proteases on reovirus infection in the respiratory tract.

Authors:  Rachel M Nygaard; Joseph W Golden; Leslie A Schiff
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

6.  Cell entry-associated conformational changes in reovirus particles are controlled by host protease activity.

Authors:  Jillann A Madren; Payel Sarkar; Pranav Danthi
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

7.  Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action.

Authors:  H W Virgin; M A Mann; B N Fields; K L Tyler
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 8.  Parallel mechanisms in neuropathogenesis of enteric virus infections.

Authors:  L A Morrison; B N Fields
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 9.  Mechanisms of viral pathogenesis. Distinct forms of reoviruses and their roles during replication in cells and host.

Authors:  M L Nibert; D B Furlong; B N Fields
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches.

Authors:  K J Silvey; A B Hutchings; M Vajdy; M M Petzke; M R Neutra
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.